FDA announces an 8/16 public meeting on Evaluating the Negative Symptoms of Schizophrenia in Clinical Trials to discuss approaches to developing drugs...
FDA issues Eugia Pharma Specialities its fourth Form FDA-483 of the year after concluding an inspection of the firms formulation manufacturing facilit...
Federal Register notice: FDA issues an order permanently debarring Angela Maria Giron from providing services in any capacity to a person that has an ...
Hyman, Phelps & McNamara senior medical device regulation expert Lisa Baumhardt critiques a recent FDA draft guidance on the Q-Submission program.
The CDER Office of Translational Sciences 2023 annual report lists achievements in seven program areas.
FDA posts a final guidance entitled Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues.
Sens. Durbin and Blumenthal introduce legislation to authorize FDA to ban the marketing of tianeptine, currently being sold as a dietary supplement.
Abbotts Thoratec unit recalls its HeartMate 3 and left ventricular assist system implant kit due to the potential for a leak.
